Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-01

FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for rabeprazole sodium (generic) submitted by Aurobindo Pharma Limited. This confirms an approved change related to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabeprazole sodium (rabeprazole)

Snippet

SUPPL AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)